Role of Biologics in Severe Allergic Asthma

Speciality: Pulmonary Medicine

Description:

A warm welcome to all the medical professionals in this interesting session on biologics target allergic asthma, easing symptoms and improving lung function in severe cases.

Biologics play a critical role in managing severe allergic asthma by targeting specific immune pathways involved in the inflammatory cascade. In individuals with severe asthma that is inadequately controlled by standard therapies, such as inhaled corticosteroids and long-acting beta-agonists, biologics offer a targeted approach to address underlying disease mechanisms.

These medications, often monoclonal antibodies, work by inhibiting key inflammatory mediators, such as interleukins or immunoglobulin E (IgE), which are implicated in allergic responses and airway inflammation. By dampening the exaggerated immune response associated with allergic asthma, biologics help reduce asthma exacerbations, improve lung function, and enhance quality of life for patients.

The selection of the most appropriate biologic therapy is guided by individual patient characteristics, including biomarker profiles such as eosinophil counts or allergic sensitization, as well as treatment response and tolerability.

Therefore, get an overall knowledge on biologics target allergic asthma, easing symptoms and improving lung function in severe cases. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.

See More Webinars @ Hidoc Webinars